Clinical trial of herbal supplement as an immunomodulator in adult Covid 19 positive patients.
Phase 2
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/026187
- Lead Sponsor
- Mr Ghanshyam Goti
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients admitted with RT-PCR confirmed COVID-19 illness.
Age > 18 & < 65 years of either sex
Mild to Moderately Covid 19 disease (NEWS score <= 8)
Signed informed consent must be obtained and documented according to AYUSH GCP, and national/local regulations.
Exclusion Criteria
Pregnant women
Breastfeeding women
Requiring ICU admission at the screening
Patients above 65 years of age and below 18 Years
Past History of MI, Epileptic episodes
Any other co-morbidity (uncontrolled diabetes, severe hypertension from subject history) which is at critical stage at the screening
Any other condition by which subject proves unfit from investigator perspective
Not giving consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method